Curriculum Vitae

Professional Experience

Since May 2021
Independent Haematologist – Centre Médical Lausanne Ouest (CMLO), Prilly

Since October 2025
Independent Haematologist – Clinique CIC Montreux, Clarens

May 2021 – February 2026
Independent Haematologist – Maison Médicale de Renens, Renens

May 2021 – September 2024
Independent Haematologist – Centre Médical Magellan, Vevey

2013 – 2020
Deputy Head Physician – Department of Oncology and Haematology, Hôpital neuchâtelois (HNE) and ADMED Laboratory, Neuchâtel
Responsible for clinical activity in haematology and involved in haematological research activities.

2011 – 2012
Hospital Practitioner – Hôpital Saint-Louis, Paris
Head of the Day Hospital, Cell Kinetics Unit, under the direction of Prof. Christine Chomienne

2006 – 2010
Specialist training in Haematology – Assistance Publique–Hôpitaux de Paris and the Paris region

Hôpital Saint-Louis – Prof. Jean-Jacques Kiladjian, Prof. Christine Chomienne
Hôpital Avicenne – Prof. Pierre Fenaux
Centre Hospitalier de Versailles – Prof. Philippe Rousselot

2008 – 2009
Locum Physician – Department of Clinical Haematology, Geneva University Hospitals (HUG), Geneva – Prof. Jakob Passweg

2004 – 2005
Residency in Internal Medicine – Larnaca and Limassol Hospitals, Cyprus

2002 – 2003
Compulsory Rural Medical Service – Sparta Hospital, Greece

Academic and Postgraduate Training

2016
Postgraduate Diploma in Management of Medical and Medico-Social Institutions – Conservatoire national des arts et métiers (CNAM), Paris, France

2011
PhD, Faculty of Medicine, National and Kapodistrian University of Athens, Greece, conducted in collaboration with INSERM, Paris.

Research focused on the JAK2 gene in myeloproliferative neoplasms, including allele burden and genotype–phenotype correlations.

2011
Specialist Qualification in Haematology – Faculty of Medicine, National and Kapodistrian University of Athens, Greece

Scientific Publications

1. Rüfer A, Angermann H, Benz R, Bonadies N, Calderoni A, Cantoni N, Efthymiou A, Escher R, Favre G, Friess D, Gschwend A, Himmelmann A, Holbro A, Keller P, Kouroupi E, et al. Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)—Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q). HemaSphere. 2022;6(7).

2. Kouroupi E, Kiladjian JJ, Dosquet C, Menot ML, Bonnin N, Adès L, Vainchenker W, Chomienne C, Cassinat B. Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN? Blood Cancer Journal. 2012;2(5).

3. Kouroupi E, Cassinat B, Schlageter MH, Dosquet C, Kiladjian JJ, Chomienne C. Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patient. American Journal of Hematology. 2012;87(6):646.

4. Kouroupi E, Kiladjian JJ, Chomienne C, Dosquet C, Bellucci S, Valla D, Cassinat B. The JAK2 46/1 haplotype in splanchnic vein thrombosis. Blood. 2011;117:5777–5778.

5. Billot S, Kouroupi E, Le Guilloux J, Cassinat B, Jardin C, Fenaux P, Carpentier AF, Kiladjian JJ. Neurological disorders in essential thrombocythemia. Haematologica. 2011;96:11–14.

6. Kouroupi E, Zoi K, Parquet N, Zoi C, Kiladjian JJ, Grigoraki V, Vainchenker W, Lellouche F, Marzac C, Schlageter MH, Dosquet C, Scott LM, Fenaux P, Loukopoulos D, Chomienne C, Cassinat B. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients. British Journal of Haematology. 2008;142:676–679.

7. Diamanti-Kandarakis E, Piperi C, Alexandraki K, Katsilambros N, Kouroupi E, Papailiou J, Lazaridis S, Koulouri E, Kandarakis HA, Douzinas EE, Creatsas G, Kalofoutis A. Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome. Metabolism. 2006;55:494–500.

8. Koullapis N, Kouroupi I, Dourakis S. Hepatobiliary manifestations of sickle cell disease. Haema. 2005;8:393–404.

Professional Qualifications and Licences to Practise

March 2011
Professional qualification in Haematology meeting the requirements of European Directive 2005/36/EC.

July 2011
Authorisation to practise as a Specialist in Haematology in Paris, France.
RPPS No. 10100238665.

June 2012
CNPH 2012 national competitive examination – Type 2, Haematology, Paris.

July 2012
Recognition of the postgraduate qualification in Haematology by MEBEKO and equivalence with the Swiss Federal Medical Diploma.

December 2013
Authorisation to practise as a Specialist in Haematology in the Canton of Neuchâtel.

October 2016
FMH registration.
FMH ID No. 95626 – GLN 7601000961457.

November 2019
Authorisation to practise as a Specialist in Haematology in the Canton of Geneva.

September 2020
Authorisation to practise as a Specialist in Haematology in the Canton of Vaud.

Since May 2021
Accredited at Clinique de La Source, CCAC, and the Hirslanden Clinique Cecil and Clinique Bois-Cerf in Lausanne.